Wednesday, 1 December 2021

First long-acting option HIV prevention approved for use

First long-acting option HIV prevention approved for use
First long-acting option HIV prevention approved for use

The first long-acting option to protect women from HIV, proven to reduce women’s HIV risk, has been recommended for use by the World Health Organization (WHO).

admin Wed, 12/01/2021 - 16:40

source https://www.pharmatutor.org/pharma-news/2021/first-long-acting-option-hiv-prevention-approved-for-use

No comments:

Post a Comment

Pharma openings

  Opportunity for M.Pharm, Msc or PhD as Scientist at PGIMER M.Pharmacy or M.Sc 6 Year of Research Experience or PhD with 3 year of Experien...